ArticleBioprocess and biosystems engineering2026
Operationalizing digital twins in biomanufacturing through interoperable process analytical technology.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The integration of Process Analytical Technologies (PAT) within digital twin architecture represents an important advancement in biopharmaceutical manufacturing. While existing literature has separately addressed digital twin dimensions, interoperability levels, and manufacturing standards, their systematic integration for real-time bioprocess control remains underexplored. Our work provides an operational framework that bridges established frameworks on digital twin dimensions with hierarchical interoperability levels. Our conceptual framework establishes an interoperability "triangle" wherein Data and Connection dimensions function as the central hub linking Physical and Virtual entities with Services to enable model-based predictive control (MPC) through PAT integration. We exemplify the practical application of our proposed approach using a galactosylation adaptive control case study that spans purpose-driven systematic technology assessment to operational deployment at the testbed. Our study provides theoretical advancement in digital twin operationalization and a practical approach for implementing MPC-enabled PAT systems in highly regulated biopharmaceutical manufacturing, with potential for applicability across multiple critical quality attributes, unit operations, and manufacturing scales.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.